$5190
$4152
The organoids services market size is projected to reach US$ 15.01 billion by 2031 from US$ 3.03 billion in 2023. The market is expected to register a CAGR of 22.3% in 2023–2031. The integration of artificial intelligence is likely to act as one of the key trends in the organoids services market in the future.
Organoids Services Market Analysis
Factors contributing to the organoids services market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.
Organoids Services Market Overview
Organoids are emerging as a powerful asset for researchers and drug developers as they seek more efficient and accurate methods to identify promising drug candidates and predict their efficacy. The ability to generate patient-derived organoids (PDOs) opens up exciting possibilities for personalized drug screening. Organoids serve as realistic and relevant models for drug screening compared to traditional 2D cell cultures. They mimic the complexity of human organs, including their cellular composition, structure, and function, providing a more accurate representation of drug responses in the human body. This enables researchers to identify potential drug candidates more confidently, and avoid costly and time-consuming setbacks in clinical trials. The organoid services market is experiencing rapid growth owing to the increasing demand for innovative screening services.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Organoids Services Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Organoids Services Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Organoids Services Market Drivers and Opportunities
Surge in Popularity of Personalized Drugs Favors Organoids Services Market
Personalized or precision medicine is the study of practices or drugs tailored to the individual patient based on the projected response or disease risk. According to a study released by the Personalized Medicine Coalition (PMC), the share of personalized medication approvals in total FDA approvals for new molecular entities rose from 5% in 2005 to over 25% in 2016. Further, 73% of compounds in the pipeline are potential oncological candidates, and 42% have the potential to be personalized therapies. Biopharmaceutical companies have virtually doubled their R&D investments in personalized pharmaceuticals. Further, in the coming years, this spending is expected to surge by 33%. Moreover, researchers in the field of biopharmaceuticals anticipate a 69% rise in the creation of customized medications during the said period. As per the most recent study published in the PMC in 2021, the number of customized medications available in the US market has jumped up from 132 in 2016 to 286 in 2020. The information was produced by tracking the PMC's numbers for personalized medication since 2008. The use of organoids to produce customized medication regimens holds significant prospects for enhancing patient care. With their active efforts to promote and raise awareness of precision medicine, pharmacists play a crucial role in driving up demand for customized medications. According to a recent published in one of the NCBI journals in 2021, more than 50% of consumers preferred to buy customized goods or services. These stats indicate the build up of a conducive environment for the growth of the organoids services market.
Key Developments by Companies to Create Opportunities for Organoids Services Market Growth
The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:
- In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products when needed.
- In January 2024, HUB Organoids (HUB) launched IntegriGut Screen services for the global market. This screening service employs IBD PDO monolayers to aid in the development of novel IBD therapies by ensuring the availability of high-quality human data on epithelial barrier function.
- In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.
- In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.
- In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.
Such key developments, launches, and strategic collaborations create ample opportunities for the organoid services market growth.
Organoids Services Market Report Segmentation Analysis
Key segments that contributed to the derivation of the organoids services market analysis are product, application, source, and manufacturing.
- Based on type, the organoids services market is classified into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the market in 2023, and it is further anticipated to register the highest CAGR during the forecast period.
- By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
- Based on source, the organoids services market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.
Organoids Services Market Share Analysis by Geography
The geographic scope of the organoids services market report is mainly divided into five regions: North America, Asia Pacific, Europe, and the Middle East & Africa.
North America dominates the organoids services market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023–2031.
Organoids Services Market Report Scope
Organoids Services Market News and Recent Developments
The organoids services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research. (InSphero, Press Release, May 2024)
Organoids Services Market Report Coverage and Deliverables
The "Organoids Services Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Organoids services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Organoids services market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter's Five Forces and SWOT analysis
- Organoids services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the organoids services market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2023.
The increasing demand for innovative drug screening services, a rise in the prevalence of skin disorders, and a surge in the popularity of personalized drugs are the key factors driving the market.
Strategic initiatives by companies would bring attractive trends in the market in the coming years.
Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key players in the market.
The estimated value of the market would be US$ 15.01 billion by 2031.
The market is expected to register a CAGR of 22.3% during 2023–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Organoids Services Market Landscape
4.1 PEST Analysis
5. Organoids Services Market – Key Market Dynamics
5.1 Organoids Services Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Demand for Innovative Drug Screening Services
5.2.2 Surge in Popularity of Personalized Drugs
5.3 Market Restraints
5.3.1 Dearth of Skilled Professionals
5.4 Market Opportunities
5.4.1 Increasing Key Developments
5.5 Future Trends
5.5.1 Integration of Artificial Intelligence
5.6 Impact of Drivers and Restraints:
6. Organoids Services Market – Global Market Analysis
6.1 Organoids Services Market Revenue (US$ Million), 2021–2031
6.2 Organoids Services Market Forecast Analysis
7. Organoids Services Market Analysis – by Type
7.1 Intestine
7.1.1 Overview
7.1.2 Intestine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Liver
7.2.1 Overview
7.2.2 Liver: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Pancreas
7.4.1 Overview
7.4.2 Pancreas: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Lung
7.5.1 Overview
7.5.2 Lung: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Brain
7.6.1 Overview
7.6.2 Brain: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Kidney
7.7.1 Overview
7.7.2 Kidney: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8. Organoids Services Market Analysis – by Application
8.1 Developmental Biology Disease
8.1.1 Overview
8.1.2 Developmental Biology Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Pathology of Infectious Disease
8.2.1 Overview
8.2.2 Pathology of Infectious Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Regenerative Medicine
8.3.1 Overview
8.3.2 Regenerative Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing
8.4.1 Overview
8.4.2 Drug Toxicity and Efficacy Testing: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine
8.5.1 Overview
8.5.2 Drug Discovery and Personalized Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
9. Organoids Services Market Analysis – by Source
9.1 Pluripotent Stem Cells
9.1.1 Overview
9.1.2 Pluripotent Stem Cells: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
9.2.1 Overview
9.2.2 Organ Specific Adult Stem Cell: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10. Organoids Services Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Organoids Services Market Overview
10.2.2 North America: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Organoids Services Market Breakdown, by Type
10.2.3.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.2.4 North America: Organoids Services Market Breakdown, by Application
10.2.4.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: Organoids Services Market Breakdown, by Source
10.2.5.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.2.6 North America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.2.1 United States: Organoids Services Market Breakdown, by Type
10.2.6.2.2 United States: Organoids Services Market Breakdown, by Application
10.2.6.2.3 United States: Organoids Services Market Breakdown, by Source
10.2.6.3 Canada: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.3.1 Canada: Organoids Services Market Breakdown, by Type
10.2.6.3.2 Canada: Organoids Services Market Breakdown, by Application
10.2.6.3.3 Canada: Organoids Services Market Breakdown, by Source
10.2.6.4 Mexico: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.4.1 Mexico: Organoids Services Market Breakdown, by Type
10.2.6.4.2 Mexico: Organoids Services Market Breakdown, by Application
10.2.6.4.3 Mexico: Organoids Services Market Breakdown, by Source
10.3 Europe
10.3.1 Europe Organoids Services Market Overview
10.3.2 Europe: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Organoids Services Market Breakdown, by Type
10.3.3.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.3.4 Europe: Organoids Services Market Breakdown, by Application
10.3.4.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: Organoids Services Market Breakdown, by Source
10.3.5.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.3.6 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.3.6.2 Germany: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.2.1 Germany: Organoids Services Market Breakdown, by Type
10.3.6.2.2 Germany: Organoids Services Market Breakdown, by Application
10.3.6.2.3 Germany: Organoids Services Market Breakdown, by Source
10.3.6.3 United Kingdom: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.3.1 United Kingdom: Organoids Services Market Breakdown, by Type
10.3.6.3.2 United Kingdom: Organoids Services Market Breakdown, by Application
10.3.6.3.3 United Kingdom: Organoids Services Market Breakdown, by Source
10.3.6.4 France: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.4.1 France: Organoids Services Market Breakdown, by Type
10.3.6.4.2 France: Organoids Services Market Breakdown, by Application
10.3.6.4.3 France: Organoids Services Market Breakdown, by Source
10.3.6.5 Italy: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.5.1 Italy: Organoids Services Market Breakdown, by Type
10.3.6.5.2 Italy: Organoids Services Market Breakdown, by Application
10.3.6.5.3 Italy: Organoids Services Market Breakdown, by Source
10.3.6.6 Spain: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.6.1 Spain: Organoids Services Market Breakdown, by Type
10.3.6.6.2 Spain: Organoids Services Market Breakdown, by Application
10.3.6.6.3 Spain: Organoids Services Market Breakdown, by Source
10.3.6.7 Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Organoids Services Market Breakdown, by Type
10.3.6.7.2 Rest of Europe: Organoids Services Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: Organoids Services Market Breakdown, by Source
10.4 Asia Pacific
10.4.1 Asia Pacific Organoids Services Market Overview
10.4.2 Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Organoids Services Market Breakdown, by Type
10.4.3.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.4.4 Asia Pacific: Organoids Services Market Breakdown, by Application
10.4.4.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.4.5 Asia Pacific: Organoids Services Market Breakdown, by Source
10.4.5.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.4.6 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.4.6.2 Japan: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.2.1 Japan: Organoids Services Market Breakdown, by Type
10.4.6.2.2 Japan: Organoids Services Market Breakdown, by Application
10.4.6.2.3 Japan: Organoids Services Market Breakdown, by Source
10.4.6.3 China: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.3.1 China: Organoids Services Market Breakdown, by Type
10.4.6.3.2 China: Organoids Services Market Breakdown, by Application
10.4.6.3.3 China: Organoids Services Market Breakdown, by Source
10.4.6.4 India: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.4.1 India: Organoids Services Market Breakdown, by Type
10.4.6.4.2 India: Organoids Services Market Breakdown, by Application
10.4.6.4.3 India: Organoids Services Market Breakdown, by Source
10.4.6.5 South Korea: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.5.1 South Korea: Organoids Services Market Breakdown, by Type
10.4.6.5.2 South Korea: Organoids Services Market Breakdown, by Application
10.4.6.5.3 South Korea: Organoids Services Market Breakdown, by Source
10.4.6.6 Australia: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.6.1 Australia: Organoids Services Market Breakdown, by Type
10.4.6.6.2 Australia: Organoids Services Market Breakdown, by Application
10.4.6.6.3 Australia: Organoids Services Market Breakdown, by Source
10.4.6.7 Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Organoids Services Market Breakdown, by Type
10.4.6.7.2 Rest of APAC: Organoids Services Market Breakdown, by Application
10.4.6.7.3 Rest of APAC: Organoids Services Market Breakdown, by Source
10.5 Middle East and Africa
10.5.1 Middle East and Africa Organoids Services Market Overview
10.5.2 Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Organoids Services Market Breakdown, by Type
10.5.3.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.5.4 Middle East and Africa: Organoids Services Market Breakdown, by Application
10.5.4.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.5.5 Middle East and Africa: Organoids Services Market Breakdown, by Source
10.5.5.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.5.6 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.5.6.2 Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.2.1 Saudi Arabia: Organoids Services Market Breakdown, by Type
10.5.6.2.2 Saudi Arabia: Organoids Services Market Breakdown, by Application
10.5.6.2.3 Saudi Arabia: Organoids Services Market Breakdown, by Source
10.5.6.3 South Africa: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.3.1 South Africa: Organoids Services Market Breakdown, by Type
10.5.6.3.2 South Africa: Organoids Services Market Breakdown, by Application
10.5.6.3.3 South Africa: Organoids Services Market Breakdown, by Source
10.5.6.4 United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: Organoids Services Market Breakdown, by Type
10.5.6.4.2 United Arab Emirates: Organoids Services Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: Organoids Services Market Breakdown, by Source
10.5.6.5 Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Type
10.5.6.5.2 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Source
10.6 South and Central America
10.6.1 South and Central America Organoids Services Market Overview
10.6.2 South and Central America: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Organoids Services Market Breakdown, by Type
10.6.3.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.6.4 South and Central America: Organoids Services Market Breakdown, by Application
10.6.4.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.6.5 South and Central America: Organoids Services Market Breakdown, by Source
10.6.5.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.6.6 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.2.1 Brazil: Organoids Services Market Breakdown, by Type
10.6.6.2.2 Brazil: Organoids Services Market Breakdown, by Application
10.6.6.2.3 Brazil: Organoids Services Market Breakdown, by Source
10.6.6.3 Argentina: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.3.1 Argentina: Organoids Services Market Breakdown, by Type
10.6.6.3.2 Argentina: Organoids Services Market Breakdown, by Application
10.6.6.3.3 Argentina: Organoids Services Market Breakdown, by Source
10.6.6.4 Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: Organoids Services Market Breakdown, by Type
10.6.6.4.2 Rest of South and Central America: Organoids Services Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: Organoids Services Market Breakdown, by Source
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Organoids Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Sino Biological Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eurofins Scientific SE
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Molecular Devices, LLC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 InSphero
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cyprio
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 InnoSer
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 LABTOO
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CUSABIO TECHNOLOGY LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Oncodesign Services
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Organoids Services Market Segmentation
Table 2. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million) – by Source
Table 6. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 7. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 8. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 9. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 10. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 11. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 12. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 13. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 14. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 16. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 17. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 18. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 19. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 20. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 22. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 23. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 24. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 26. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 27. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 28. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 29. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 30. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 31. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 32. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 33. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 34. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 35. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 36. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 38. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 39. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 41. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 42. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 43. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 44. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 45. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 46. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 47. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 48. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 49. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 51. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 52. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 53. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 54. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 55. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 56. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 57. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 58. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 59. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 60. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 61. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 63. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 64. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 66. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 67. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 68. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 70. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 71. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 72. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 73. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 74. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 75. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 76. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 77. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 79. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 80. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 81. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 82. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 83. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 84. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 86. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 87. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 88. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 89. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 90. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 91. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 92. Recent Organic Growth Strategies in Organoids Services Market
Table 93. Recent Inorganic Growth Strategies in the Organoids Services Market
Table 94. Glossary of Terms, Organoids Services Market
List of Figures
Figure 1. Organoids Services Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organoids Services Market Revenue (US$ Million), 2021–2031
Figure 5. Organoids Services Market Share (%) – by Type (2023 and 2031)
Figure 6. Intestine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Liver: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Stomach: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Pancreas: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lung: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Brain: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Kidney: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Organoids Services Market Share (%) – by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Regenerative Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Organoids Services Market Share (%) – by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Organ Specific Adult Stem Cell: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Organoids Services Market Breakdown by Region, 2023 and 2031 (%)
Figure 25. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. North America: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 27. North America: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 28. North America: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 29. North America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 35. Europe: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 36. Europe: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 37. Europe: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 38. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Asia Pacific: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 46. Asia Pacific: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 47. Asia Pacific: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 48. Asia Pacific: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Middle East and Africa: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 57. Middle East and Africa: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 58. Middle East and Africa: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 59. Middle East and Africa: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 60. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 61. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 62. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 63. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 64. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 65. South and Central America: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 66. South and Central America: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 67. South and Central America: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 68. South and Central America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 69. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. Growth Strategies in Organoids Services Market
The List of Companies - Organoids Services Market
- Sino Biological Inc.
- Eurofins Scientific SE
- Molecular Devices, LLC.
- InSphero;
- Cyprio
- InnoSer
- LABTOO
- CUSABIO TECHNOLOGY LLC
- Oncodesign Services
- HUB Organoids B.V. (Hubrecht Organoid Technology)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Organoids Services Market
Aug 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Aug 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Aug 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2024
Bioreactors Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization), and Geography
Aug 2024
Poultry Diagnostics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others], Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others), and Geography
Aug 2024
ELISA Diagnostics Tests Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography
Aug 2024
Direct-To-Consumer Genetic Testing Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Test Type (Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), Distribution Channel (Online and Offline), and Geography
Aug 2024
Transient Protein Expression Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)